Corvus Pharmaceuticals, Inc.
NasdaqGM:CRVS 株式レポート
Corvus Pharmaceuticals 将来の成長
Corvus Pharmaceuticalsは、7.1%と76.9%でそれぞれ年率7.1%で利益と収益が成長すると予測される一方、EPSはgrowで14.9%年率。
主要情報
Biotechs 収益成長 | 27.3% |
収益成長率 | 76.9% |
将来の株主資本利益率 | n/a |
アナリストカバレッジ | Low |
最終更新日 | 22 Oct 2024 |
今後の成長に関する最新情報
Corvus Pharmaceuticals: Soquelitinib's High Stakes In PTCL Therapy
Sep 02Will Corvus Pharmaceuticals (NASDAQ:CRVS) Spend Its Cash Wisely?
Mar 06Here's Why We're Watching Corvus Pharmaceuticals' (NASDAQ:CRVS) Cash Burn Situation
Oct 23Is Corvus Pharmaceuticals (NASDAQ:CRVS) In A Good Position To Invest In Growth?
May 16Here's Why We're Watching Corvus Pharmaceuticals' (NASDAQ:CRVS) Cash Burn Situation
Dec 05Corvus' partner Angel Pharma gets nod to start phase 1/1b trial of cancer therapy in China
Sep 26We're Keeping An Eye On Corvus Pharmaceuticals' (NASDAQ:CRVS) Cash Burn Rate
Aug 14Companies Like Corvus Pharmaceuticals (NASDAQ:CRVS) Are In A Position To Invest In Growth
Apr 05We're Hopeful That Corvus Pharmaceuticals (NASDAQ:CRVS) Will Use Its Cash Wisely
Dec 15Checking In On Corvus Pharmaceuticals
Dec 10Corvus: Surging On AstraZeneca CD73 Success With Key Data Readout Looming
Sep 22We Think Corvus Pharmaceuticals (NASDAQ:CRVS) Can Afford To Drive Business Growth
Aug 26Corvus Pharmaceuticals initiated buy at Cantor with a Street-high target
May 27Is Corvus Pharmaceuticals (NASDAQ:CRVS) In A Good Position To Deliver On Growth Plans?
May 08The Co-Founder of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), Richard Miller, Just Bought 8.5% More Shares
Feb 19Here's Why We're Watching Corvus Pharmaceuticals' (NASDAQ:CRVS) Cash Burn Situation
Feb 07Here's What Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) Shareholder Ownership Structure Looks Like
Dec 16Corvus Pharmaceuticals EPS misses by $0.06
Oct 29業績と収益の成長予測
NasdaqGM:CRVS - アナリストの将来予測と過去の財務データ ( )USD Millions日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|
12/31/2026 | 5 | -47 | -40 | N/A | 5 |
12/31/2025 | 1 | -37 | -29 | N/A | 5 |
12/31/2024 | N/A | -25 | -22 | N/A | 5 |
6/30/2024 | N/A | -23 | -21 | -21 | N/A |
3/31/2024 | N/A | -25 | -21 | -21 | N/A |
12/31/2023 | N/A | -27 | -24 | -24 | N/A |
9/30/2023 | N/A | -30 | -26 | -26 | N/A |
6/30/2023 | N/A | -39 | -28 | -28 | N/A |
3/31/2023 | N/A | -41 | -29 | -29 | N/A |
12/31/2022 | N/A | -41 | -27 | -27 | N/A |
9/30/2022 | N/A | -41 | -27 | -26 | N/A |
6/30/2022 | N/A | -37 | -28 | -28 | N/A |
3/31/2022 | N/A | -40 | -34 | -34 | N/A |
12/31/2021 | N/A | -43 | -37 | -37 | N/A |
9/30/2021 | N/A | -7 | -38 | -38 | N/A |
6/30/2021 | N/A | -6 | -37 | -37 | N/A |
3/31/2021 | N/A | -5 | -34 | -34 | N/A |
12/31/2020 | N/A | -6 | -35 | -35 | N/A |
9/30/2020 | N/A | -44 | -35 | -35 | N/A |
6/30/2020 | N/A | -46 | -38 | -38 | N/A |
3/31/2020 | N/A | -48 | -38 | -38 | N/A |
12/31/2019 | N/A | -47 | -37 | -37 | N/A |
9/30/2019 | N/A | -46 | -37 | -37 | N/A |
6/30/2019 | N/A | -46 | -38 | -37 | N/A |
3/31/2019 | N/A | -44 | -39 | -39 | N/A |
12/31/2018 | N/A | -47 | -41 | -41 | N/A |
9/30/2018 | N/A | -48 | -44 | -44 | N/A |
6/30/2018 | N/A | -51 | -44 | -44 | N/A |
3/31/2018 | N/A | -54 | N/A | -45 | N/A |
12/31/2017 | N/A | -56 | N/A | -46 | N/A |
9/30/2017 | N/A | -55 | N/A | -45 | N/A |
6/30/2017 | N/A | -52 | N/A | -41 | N/A |
3/31/2017 | N/A | -46 | N/A | -35 | N/A |
12/31/2016 | N/A | -36 | N/A | -28 | N/A |
9/30/2016 | N/A | -31 | N/A | -22 | N/A |
6/30/2016 | N/A | -24 | N/A | -19 | N/A |
3/31/2016 | N/A | -36 | N/A | -15 | N/A |
12/31/2015 | N/A | -31 | N/A | -11 | N/A |
9/30/2015 | N/A | -25 | N/A | -7 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: CRVS今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: CRVS今後 3 年間、利益が出ない状態が続くと予測されています。
高成長収益: CRVS今後 3 年間、利益が出ない状態が続くと予測されています。
収益対市場: CRVSの収益 ( 76.9% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。
高い収益成長: CRVSの収益 ( 76.9% ) 20%よりも速いペースで成長すると予測されています。
将来の株主資本利益率
将来のROE: CRVSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}